The Appropriate Elicitation of Expert Opinion in Economic Models
暂无分享,去创建一个
[1] Mark Sculpher,et al. Subgroups and Heterogeneity in Cost-Effectiveness Analysis , 2012, PharmacoEconomics.
[2] Ron L Akehurst. Making decisions on technology availability in the British National Health Service--why we need reliable models. , 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[3] S. Golder,et al. Good Practice Guidelines for Decision-Analytic Modelling in Health Technology Assessment , 2012, PharmacoEconomics.
[4] Wolf D. Rauch,et al. The decision Delphi , 1979 .
[5] Karl Claxton,et al. Characterizing structural uncertainty in decision analytic models: a review and application of methods. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[6] Sarah Wordsworth,et al. Eliciting expert opinion for economic models: an applied example. , 2007, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[7] M. Sculpher,et al. Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra. , 2005, Health economics.
[8] Jonathan Karnon,et al. A Critique and Impact Analysis of Decision Modeling Assumptions , 2007, Medical decision making : an international journal of the Society for Medical Decision Making.
[9] J Chilcott,et al. The role of modelling in prioritising and planning clinical trials. , 2003, Health technology assessment.
[10] Andrew Briggs,et al. Value based pricing for NHS drugs: an opportunity not to be missed? , 2008, BMJ : British Medical Journal.
[11] Karl Claxton,et al. The Value of Implementation and the Value of Information: Combined and Uneven Development , 2008, Medical decision making : an international journal of the Society for Medical Decision Making.
[12] Per Lindqvist,et al. (Mis-?) using the E-Delphi method. An Attempt to Articulate Practical Knowledge of Teaching , 2007 .
[13] Kathy K. Franklin,et al. Idea Generation and Exploration: Benefits and Limitations of the Policy Delphi Research Method , 2006 .
[14] M. Drummond,et al. The Iterative Use of Economic Evaluation as Part of the Process of Health Technology Assessment , 1997, Journal of health services research & policy.
[15] Jeremy E. Oakley,et al. Uncertain Judgements: Eliciting Experts' Probabilities , 2006 .
[16] Katherine Payne,et al. Fish and chips all round? Regulation of DNA-based genetic diagnostics. , 2009, Health economics.
[17] Laura Vallejo-Torres,et al. Integrating health economics modeling in the product development cycle of medical devices: A Bayesian approach , 2008, International Journal of Technology Assessment in Health Care.
[18] C M Goodman,et al. The Delphi technique: a critique. , 1987, Journal of advanced nursing.
[19] C. Evans,et al. Expert judgement in pharmacoeconomic studies. Guidance and future use. , 2000, PharmacoEconomics.
[20] W. Newman,et al. Understanding chemotherapy treatment pathways of advanced colorectal cancer patients to inform an economic evaluation in the United Kingdom , 2010, British Journal of Cancer.
[21] Milton C Weinstein,et al. Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies. , 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.